Cookies Policy
X

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

I accept this policy

Find out more here

Possible mechanisms of low levels of plasma valproate concentration following simultaneous administration of sodium valproate and meropenem

No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.

Brill’s MyBook program is exclusively available on BrillOnline Books and Journals. Students and scholars affiliated with an institution that has purchased a Brill E-Book on the BrillOnline platform automatically have access to the MyBook option for the title(s) acquired by the Library. Brill MyBook is a print-on-demand paperback copy which is sold at a favorably uniform low price.

This Article is currently unavailable for purchase.
Add to Favorites
You must be logged in to use this functionality

Cover image Placeholder

Drug interaction between meropenem (MEPM), a carbapenem of antibiotic agent, and sodium valproate (VPA), an anticonvulsant, was studied in rats and human volunteers. When sodium VPA and MEPM were administered simultaneously, the plasma VPA level was significantly lower and the blood cell/plasma VPA concentration ratio was significantly higher than after the administration of sodium VPA alone (control). Following the simultaneous administration of sodium VPA and MEPM, the pharmacokinetic parameters such as plasma VPA, volume of distribution (Vd) and clearance (CL) were significantly increased, while the maximum plasma concentration (Cmax) and area under the plasma concentration- time curve (AUC) till 3 h were significantly decreased. The ratio of free (unbound) VPA to protein-bound VPA was significantly increased after the administration of MEPM. The concentration of VPA in brain tissue was significantly decreased after the simultaneous administration of VPA and MEPM. Competition between VPA and MEPM for a protein binding site resulted in increased plasma levels of free (unbound) VPA, which then distributed to various tissues, in particular, the blood cells, liver and kidney. VPA which distributed to the liver was metabolized there and excreted. Subsequently, the levels of VPA in the plasma and brain would be significantly decreased.

10.1163/15693910260698357
/content/journals/10.1163/15693910260698357
dcterms_title,pub_keyword,dcterms_description,pub_author
10
5
Loading
Loading

Full text loading...

/content/journals/10.1163/15693910260698357
Loading

Data & Media loading...

http://brill.metastore.ingenta.com/content/journals/10.1163/15693910260698357
Loading

Article metrics loading...

/content/journals/10.1163/15693910260698357
2017-09-20

Sign-in

Can't access your account?
  • Key

  • Full access
  • Open Access
  • Partial/No accessInformation